Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Interest Receivables (2023 - 2025)

Historic Change in Interest Receivables for iBio (IBIO) over the last 3 years, with Q4 2025 value amounting to $20000.0.

  • iBio's Change in Interest Receivables rose 4285.71% to $20000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $68000.0, marking a year-over-year decrease of 1168.83%. This contributed to the annual value of $62000.0 for FY2025, which is 2954.55% down from last year.
  • As of Q4 2025, iBio's Change in Interest Receivables stood at $20000.0, which was up 4285.71% from $19000.0 recorded in Q3 2025.
  • iBio's 5-year Change in Interest Receivables high stood at $22000.0 for Q3 2023, and its period low was $14000.0 during Q4 2024.
  • Moreover, its 3-year median value for Change in Interest Receivables was $19500.0 (2024), whereas its average is $18900.0.
  • Its Change in Interest Receivables has fluctuated over the past 5 years, first crashed by 3636.36% in 2024, then soared by 4285.71% in 2025.
  • Over the past 3 years, iBio's Change in Interest Receivables (Quarter) stood at $22000.0 in 2023, then plummeted by 36.36% to $14000.0 in 2024, then soared by 42.86% to $20000.0 in 2025.
  • Its Change in Interest Receivables was $20000.0 in Q4 2025, compared to $19000.0 in Q3 2025 and $15000.0 in Q2 2025.